Study guide
4.3 Case Report Forms (CRFs) & Source Documentation
SOCRA CCRP Certified Clinical Research Professional Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Ethical Codes & Guidelines
1.1 The Nuremberg Code (1947) 1.2 The Declaration of Helsinki (1964) 1.3 The Belmont Report (1979)
2 Chapter 2: U.S. Federal Regulatory Framework
2.1 FDA vs. HHS Governance & 45 CFR Part 46 2.2 Electronic Records & Signatures (21 CFR Part 11) 2.3 Financial Disclosure Requirements (21 CFR Part 54)
3 Chapter 3: Institutional Review Boards & Informed Consent
3.1 IRB Structure, Roles, and Responsibilities (21 CFR Part 56) 3.2 Informed Consent Core Elements & Process (21 CFR Part 50) 3.3 Informed Consent in Special Circumstances & Exceptions 3.4 Vulnerable Populations & Additional Safeguards (Subparts B, C, D)
4 Chapter 4: Protocol & Essential Documentation
4.1 Protocol Design and Investigator's Brochure (ICH E6 Section 6 & 7) 4.2 Essential Documents Checklist (ICH E6 Section 8) 4.3 Case Report Forms (CRFs) & Source Documentation
5 Chapter 5: Investigational Applications (IND & IDE)
5.1 Investigational New Drug (IND) Applications (21 CFR Part 312) 5.2 Investigational Device Exemptions (IDE) & Device Classification (21 CFR Part 812) 5.3 Expanded Access & Humanitarian Device Exemptions (HDE)
6 Chapter 6: Investigator & Sponsor Responsibilities
6.1 Investigator Responsibilities & Delegation (ICH E6 4.0 / 21 CFR 312.60) 6.2 Sponsor Roles, Responsibilities, and Quality Management (ICH E6 5.0) 6.3 Financial Agreements, Contracts, and Insurance
7 Chapter 7: Study Implementation & Clinical Operations
7.1 Subject Recruitment, Screening, and Enrolling Procedures 7.2 Investigational Product (IP) Receipt, Accountability, and Disposition 7.3 Protocol Compliance, Deviations, and Corrective Action Plans
8 Chapter 8: Safety Definitions & Reporting Workflows
8.1 Adverse Events, Serious Adverse Events, and SUSARs (ICH E2A) 8.2 Safety Reporting Timelines (Investigator-Sponsor-FDA-IRB) 8.3 Device-Related Safety Reporting & Unanticipated Adverse Device Effects (UADEs)
9 Chapter 9: Quality Assurance, Monitoring, and Auditing
9.1 Clinical Site Monitoring (Traditional vs. Risk-Based Monitoring) 9.2 Sponsor Audits vs. Regulatory Inspections 9.3 FDA BIMO Inspections, Form 483, and Warning Letters
10 Chapter 10: Study Closure & Final Disclosures
10.1 Close-Out Visits and Administrative Wrap-Up 10.2 Record Retention Regulations (FDA vs. ICH GCP) 10.3 Final Reporting & Registration (ClinicalTrials.gov / 42 CFR 11)
4.3 Case Report Forms (CRFs) & Source Documentation
Key Takeaways Explain This Topic AI
ALCOA-C is the regulatory acronym representing data integrity: Attributable, Legible, Contemporaneous, Original, Accurate, and Complete.
Under 21 CFR Part 11, electronic data capture systems must maintain secure, computer-generated, time-stamped audit trails.
Source data refers to the original records of clinical observations; Case Report Forms (CRFs) transcribe this data for sponsor analysis.
Paper document corrections require a single line strike-through, the correct value, initials, date, and a reason, without obscuring the original.
A Certified Copy must be verified with a dated signature or a validated process to confirm it has the exact information as the original.
Last updated: July 2026
- 4.3 Case Report Forms (CRFs) & Source Documentation
- Definitions and Data Flow
Data integrity is the foundation of any clinical trial. To evaluate the safety and efficacy of an investigational product, regulatory agencies rely on a clear, unbroken line of evidence. This line starts with Source Data , is recorded in Source Documents , is transcribed into the Case Report Form (CRF) or Electronic Case Report Form (eCRF), and is ultimately analyzed in the clinical database.
Source Data vs. Source Documents
It is vital to distinguish between data and the media on which they are recorded:
Source Data : All information in original records and certified copies of original records of clinical findings, observations, or other activities in a clinical trial necessary for the reconstruction and evaluation of the trial.
Source Documents : The physical or electronic media where source data are first recorded. Under ICH E6 , source documents include hospital records, clinical and office charts, laboratory notes, memoranda, subjects' diaries or evaluation checklists, pharmacy dispensing records, recorded data from automated instruments, and copies or transcriptions certified after verification as being accurate copies.
The Case Report Form (CRF) is a printed, optical, or electronic document designed to record all protocol-required information to be reported to the sponsor on each trial subject. The CRF is not a source document unless specifically defined as such in the protocol or a written site agreement (e.g., when a subject-completed quality of life questionnaire is completed directly on a tablet, making the electronic record the source).
CRF Design and Best Practices
The design of the CRF is critical to both trial efficiency and data quality. Poorly designed CRFs lead to data entry errors, high query rates, and protocol deviations. Best practices in CRF design include:
Objective-Driven Design : Every data field on the CRF must correspond directly to a protocol objective, endpoint, or safety parameter. Collecting unnecessary "nice-to-know" data increases site burden and the risk of data entry errors.
Structured Data Collection : Minimizing free-text fields in favor of check boxes, radio buttons, drop-down menus, and standardized date/time formats. This ensures data consistency and simplifies statistical analysis.
Data Validation Rules : For eCRFs, implementing real-time edit checks (e.g., range checks that prevent entering a diastolic blood pressure of 800 mmHg, or logical checks that prevent a male subject from having a recorded pregnancy test).
Compliance with 21 CFR Part 11
Modern clinical trials utilize electronic data capture (EDC) systems. These systems must comply with 21 CFR Part 11 , the FDA's regulations governing electronic records and electronic signatures. Under Part 11, the EDC system must provide:
System Validation : Proof that the software performs accurately, reliably, and consistently.
Audit Trails : A secure, computer-generated, time-stamped audit trail that records the date, time, and operator of any entry, modification, or deletion of data. The original data must never be overwritten or obscured.
Security Controls : Limited system access restricted to authorized users via unique username and password combinations.
Electronic Signatures : Signatures that are legally binding, unique to the individual, and linked to their respective electronic records. PIs must electronically sign CRFs to attest to data accuracy.
The Document Trail and ALCOA-C Principles
To ensure data quality, all source documentation and CRF entries must adhere to the ALCOA-C principles. This acronym represents the gold standard for clinical data integrity:
Principle Meaning Clinical Site Application
A ttributable Every entry is traceably linked to the person who recorded it. Signatures, initials, and dates on paper records; unique logins in electronic systems.
L egible All records must be easy to read and understand. Writing clearly in blue or black ink (never pencil); avoiding shorthand that is not standard.
C ontemporaneous Data must be recorded at the time the activity occurs. Recording vitals during the visit, not from memory at the end of the day. No back-dating.
O riginal The first, raw recording of the data is preserved. Using the actual paper log or electronic record; utilizing certified copies if originals are duplicated.
A ccurate Data must be true, honest, and free from errors. Verifying entries against source notes; correcting mistakes transparently.
C omplete All required data points are present with no unexplained gaps. Documenting why a laboratory test was missed or why a subject skipped a question.
Resolving Data Queries and Correcting Records
During the trial, the sponsor's clinical monitor (CRA) or data manager will review the CRF data against the source documents (a process known as Source Data Verification or SDV ). Discrepancies generate a data query .
The Query Resolution Process
Query Generation : The monitor or data manager flags a discrepancy (e.g., CRF shows a heart rate of 72 bpm, but source notes show 172 bpm).
Site Review : Only authorized site staff (usually the coordinator or investigator) can review the query and make changes. The sponsor's monitor is legally forbidden from altering site data.
Data Correction : If an error is confirmed, the site staff updates the record.
In paper records : The staff draws a single line through the error, writes the correct value nearby, and initials and dates the change. Correction fluid (Wite-Out) or erasing is strictly prohibited. The original entry must remain visible.
In electronic records : The staff updates the field in the EDC system. The system automatically updates the electronic audit trail , prompting the user to select or enter a reason for the change (e.g., "transcription error").
Query Closure : The monitor reviews the correction and closes the query.
Certified Copies
When an original source document cannot be retained at the site (e.g., a patient's medical records from an external hospital), a Certified Copy must be created. Under ICH E6, a certified copy is a copy (irrespective of the type of media used) of the original record that has been verified (i.e., by a dated signature or by a generation through a validated process) to have the same information, including data that describe the context, content, and structure, as the original.